Floatz logo

Capsaicin

Myofascial Pain Syndrome

Stamford HospitalSmall moleculePhase 2Dormant
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
95/ 100

Competitive context

7 Active assets in the Myofascial Pain Syndrome cohort.

Asset / SponsorPhaseRating
Granisetron
Karolinska Institutet
Phase 4BB
Imc-1
Innovative Med Concepts, LLC
Phase 2B
Solvazinc
Cairo University
Early Phase 1C
BICARBONATE ION
Cairo University
N/AD
DEXTROSE
Ankara University
D

View all 12 →

Same molecule, other indications

Capsaicin is also rated in:

peripheral nervous system disorderDormant
A
Indicative ·
81 / 100
View asset →
diabetic neuropathyDormant
BBB
Indicative ·
78 / 100
View asset →
postherpetic neuralgiaDormant
BBB
Indicative ·
77 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →